In a 30-year-old sexually active woman with a painful genital vesicle, bilateral inguinal lymphadenopathy, a negative Tzanck smear, and a negative Venereal Disease Research Laboratory (VDRL) assay, which medication is most appropriate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Acyclovir is the Most Appropriate Treatment

For this patient with a first clinical episode of genital herpes, acyclovir is the definitive treatment of choice (Answer A). The clinical presentation of a painful genital vesicle with bilateral inguinal lymphadenopathy in a sexually active young woman is classic for genital herpes simplex virus (HSV) infection, even with a negative Tzanck smear.

Clinical Reasoning

The negative Tzanck smear does not rule out HSV infection—this test has poor sensitivity and frequently produces false negatives. The negative VDRL excludes syphilis. The clinical picture strongly suggests first-episode genital herpes:

  • Painful vesicular lesion (HSV lesions are characteristically painful, unlike chancroid or syphilis)
  • Bilateral inguinal lymphadenopathy (common in primary HSV)
  • Sexually active patient
  • Negative syphilis testing

Treatment Recommendation

The CDC guidelines consistently recommend acyclovir as the first-line treatment for first clinical episodes of genital herpes 1, 2. The specific regimens are:

  • Acyclovir 400 mg orally three times daily for 7-10 days, OR
  • Acyclovir 200 mg orally five times daily for 7-10 days 2

The 400 mg three-times-daily regimen is more practical for patient adherence due to less frequent dosing 2.

Why Other Options Are Incorrect

  • Ceftriaxone (B): Used for gonorrhea or chancroid, not HSV. Chancroid typically presents with painful ulcers (not vesicles) and unilateral lymphadenopathy.

  • Foscarnet (C): Reserved exclusively for acyclovir-resistant HSV in immunocompromised patients 3. This immunocompetent patient should receive standard acyclovir first.

  • Ribavirin (D): Not indicated for HSV infection—used for viral hemorrhagic fevers and hepatitis C.

  • Vancomycin (E): An antibiotic for gram-positive bacteria, completely inappropriate for viral infection.

Important Clinical Considerations

Treatment should be initiated immediately based on clinical diagnosis without waiting for confirmatory testing 2. The guidelines emphasize that systemic acyclovir provides partial control of symptoms and signs when used to treat first clinical episodes 1.

Key counseling points for this patient:

  • Genital herpes is a recurrent, incurable viral disease
  • Asymptomatic viral shedding occurs and can transmit infection
  • Abstain from sexual activity while lesions are present
  • Use condoms during all sexual exposures
  • Inform future healthcare providers, especially if pregnancy occurs 1, 2

The patient should be advised that treatment may need to be extended beyond 10 days if healing is incomplete 2. Follow-up should assess for recurrences and discuss suppressive therapy options if frequent recurrences develop (≥6 per year).

Related Questions

What is the appropriate acyclovir dosing regimen for healthy patients aged 12 years and older, children, immunocompromised patients, pregnant women, and patients with renal impairment?
What are the antiviral dosing regimens for primary, recurrent, and suppressive treatment of genital herpes simplex in an adult with normal renal function?
What is the recommended acyclovir dosing for a patient on hemodialysis, including oral and intravenous regimens?
A patient has a rapidly developing blister that is not improving with antiviral therapy and is worsening—what is the appropriate evaluation and management?
What is the appropriate acyclovir dosage for treating herpes simplex virus infection in an otherwise healthy adult?
In an adult inpatient with normal liver and kidney function, how quickly can duloxetine be increased?
How should a suspected case of Ménière's disease be evaluated?
Could my generalized muscle weakness, shaking on waking, chest cramping, normal complete blood count and comprehensive metabolic panel, and a high‑titer antinuclear antibody (ANA) with anti‑RNP antibodies indicate a life‑threatening condition?
Is abdominal pain and nausea after an Ozempic (semaglutide) dose an expected side effect, and can the patient continue the medication if the symptoms are not severe?
What are the recommended intravenous and oral treatments, including dosing, formulation, and duration, for sciatica, and what alternatives should be used for patients with drug allergies?
Why should we measure KCO (transfer coefficient for carbon monoxide) in addition to DLCO (diffusing capacity of the lung for carbon monoxide) rather than relying on DLCO alone?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.